Épisodes

  • Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice

    Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
    Sep 19 2025

    Are you up to date on new treatment options for thyroid eye disease?

    Credit available for this activity expires: 9/17/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002870?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    29 min
  • Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway

    Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway
    Sep 18 2025

    Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).

    Credit available for this activity expires: 9/18/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    37 min
  • Targeted Therapies for NSCLC: Where Are We Today?

    Targeted Therapies for NSCLC: Where Are We Today?
    Sep 11 2025

    Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

    Credit available for this activity expires: 9/10/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    38 min
  • Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025

    Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025
    Sep 9 2025

    Do you know the latest in obesity management?

    Credit available for this activity expires: 9/5/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002891?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    21 min
  • Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy

    Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy
    Sep 4 2025

    Do you know where immunotherapy fits in the treatment paradigm of squamous cell anal carcinoma?

    Credit available for this activity expires: 9/3/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002850?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    33 min
  • Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?

    Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?
    Sep 3 2025

    The power to change lives and save lives: expert advice on how to recognize where action needs to be taken and what to do.

    Credit available for this activity expires: 9/2/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002731?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    34 min
  • Illuminating the Path: New Insights in EGFR-Mutated Advanced NSCLC

    Illuminating the Path: New Insights in EGFR-Mutated Advanced NSCLC
    Aug 29 2025

    Are you aware of the latest developments for treating EGFR mutation–positive advanced/metastatic NSCLC?

    Credit available for this activity expires: 8/29/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002869?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    33 min
  • Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer

    Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer
    Aug 26 2025

    Can you give patients one ADC after another? A renowned panel of experts interrogate this question and many more in this thought-provoking program.

    Credit available for this activity expires: 8/25/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002851?ecd=bdc_podcast_libsyn_mscpedu
    Voir plus Voir moins
    28 min